APO Research
Talk to an analyst

APO RESEARCH · REPORT

Enoxaparin Sodium

Enoxaparin sodium is an anticoagulant medication (blood thinner).It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein.It is also used during hemodialysis.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Enoxaparin sodium is an anticoagulant medication (blood thinner).It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein.It is also used during hemodialysis.

Selected research

Market Outlook & Growth Opportunities

Global Enoxaparin Sodium Market Outlook and Growth Opportunities 2026

30 December 2025211 pages

Choose your research edition.

Industry ResearchEnoxaparin Sodium Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Enoxaparin Sodium Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Enoxaparin Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Enoxaparin Sodium Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Enoxaparin Sodium Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

Enoxaparin sodium is an anticoagulant medication (blood thinner).It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein.It is also used during hemodialysis.

Europe is the largest market of Enoxaparin Sodium, with about 60% market share, followed by North America with about 17% market share. Currently, there are many players in this market.Sanofi, Teva, Techdow (Hepalink), Fresenius Kabi, Rovi, Amphastar, Nanjing King-friend, Sandoz and some others are playing important roles in Enoxaparin sodium injection industry. Sanofi, Teva, Techdow (Hepalink), Fresenius Kabi and Rovi are the top 5 players of Enoxaparin Sodium, with about 85% market shares.

There are nine different dosage form of Enoxaparin Sodium. The market can be segmented into 20 mg/0.2mL, 30 mg/0.3mL, 40 mg/0.4mL, 60 mg/0.6mL, 80 mg/0.8mL, 100 mg/1mL, 120 mg/0.8mL, 150 mg/1mL, 300mg/3mL. 40 mg/0.4mL is almost the only used and efficient types and took 40% market share. By application, Hospital is the largest consumer group, with market share of 63%.

Read the full market overview

This report provides an overview of the global Enoxaparin Sodium market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Enoxaparin Sodium and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Enoxaparin Sodium sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Enoxaparin Sodium market size, projected growth trends, production technologies, key applications, and end-use industries.

Enoxaparin Sodium Segment by Company

Sanofi

Teva

Techdow (Hepalink)

Fresenius Kabi

Rovi

Amphastar

Nanjing King-friend

Sandoz

Apotex

Hangzhou Jiuyuan Gene Engineering

Cipla

Taj Pharma

Chengdu Baiyu Pharmaceutical

Suzhou Erye Pharmaceutical

Changzhou Qianhong Bio-pharma

Hebei Changshan Biochemical Pharmaceutical

Beijing SL Pharmaceutical

Huadong Medicine

Bharat Serums

INTAS

LUPIN

Troikaa Pharmaceuticals

Aristopharma

Fosun Pharma

SciencePharma

PISA

Enoxaparin Sodium Segment by Type

20 mg/0.2mL

30 mg/0.3mL

40 mg/0.4mL

60 mg/0.6mL

80 mg/0.8mL

100 mg/1mL

120 mg/0.8mL

150 mg/1mL

300mg/3mL

Enoxaparin Sodium Segment by Application

Hospital

Clinic

Others

Enoxaparin Sodium Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Enoxaparin Sodium status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Enoxaparin Sodium market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Enoxaparin Sodium significant trends, drivers, influence factors in global and regions.

6. To analyze Enoxaparin Sodium competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enoxaparin Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enoxaparin Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enoxaparin Sodium.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Enoxaparin Sodium market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Enoxaparin Sodium industry.

Chapter 3: Detailed analysis of Enoxaparin Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Enoxaparin Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Enoxaparin Sodium in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Enoxaparin Sodium Industry Trends Table 2. Enoxaparin Sodium Industry Drivers Table 3. Enoxaparin Sodium Industry Opportunities and Challenges Table 4. Enoxaparin Sodium Industry Restraints Table 5. Global Enoxaparin Sodium Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Enoxaparin Sodium Revenue Share by Company (2021-2026) Table 7. Global Enoxaparin Sodium Sales Volume by Company (M Units) & (2021-2026) Table 8. Global Enoxaparin Sodium Sales Volume Share by Company (2021-2026) Table 9. Global Enoxaparin Sodium Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Enoxaparin Sodium Company Ranking, (2024-2026) & (USD Million) Table 11. Global Enoxaparin Sodium Key Company Manufacturing Base & Headquarters Table 12. Global Enoxaparin Sodium Company, Product Type & Application Table 13. Global Enoxaparin Sodium Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Enoxaparin Sodium by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 20 mg/0.2mL Table 18. Significant Companies of 30 mg/0.3mL Table 19. Significant Companies of 40 mg/0.4mL Table 20. Significant Companies of 60 mg/0.6mL Table 21. Significant Companies of 80 mg/0.8mL Table 22. Significant Companies of 100 mg/1mL Table 23. Significant Companies of 120 mg/0.8mL Table 24. Significant Companies of 150 mg/1mL Table 25. Significant Companies of 300mg/3mL Table 26. Global Enoxaparin Sodium Sales Volume by Type 2021 VS 2025 VS 2032 (M Units) Table 27. Global Enoxaparin Sodium Sales Volume by Type (2021-2026) & (M Units) Table 28. Global Enoxaparin Sodium Sales Volume by Type (2027-2032) & (M Units) Table 29. Global Enoxaparin Sodium Sales Volume Share by Type (2021-2026) Table 30. Global Enoxaparin Sodium Sales Volume Share by Type (2027-2032) Table 31. Global Enoxaparin Sodium Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Enoxaparin Sodium Sales Value by Type (2021-2026) & (US$ Million) Table 33. Global Enoxaparin Sodium Sales Value by Type (2027-2032) & (US$ Million) Table 34. Global Enoxaparin Sodium Sales Value Share by Type (2021-2026) Table 35. Global Enoxaparin Sodium Sales Value Share by Type (2027-2032) Table 36. Significant Companies of Hospital Table 37. Significant Companies of Clinic Table 38. Significant Companies of Others Table 39. Global Enoxaparin Sodium Sales Volume by Application 2021 VS 2025 VS 2032 (M Units) Table 40. Global Enoxaparin Sodium Sales Volume by Application (2021-2026) & (M Units) Table 41. Global Enoxaparin Sodium Sales Volume by Application (2027-2032) & (M Units) Table 42. Global Enoxaparin Sodium Sales Volume Share by Application (2021-2026) Table 43. Global Enoxaparin Sodium Sales Volume Share by Application (2027-2032) Table 44. Global Enoxaparin Sodium Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Enoxaparin Sodium Sales Value by Application (2021-2026) & (US$ Million) Table 46. Global Enoxaparin Sodium Sales Value by Application (2027-2032) & (US$ Million) Table 47. Global Enoxaparin Sodium Sales Value Share by Application (2021-2026) Table 48. Global Enoxaparin Sodium Sales Value Share by Application (2027-2032) Table 49. Global Enoxaparin Sodium Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 50. Global Enoxaparin Sodium Sales by Region (2021-2026) & (M Units) Table 51. Global Enoxaparin Sodium Sales Market Share by Region (2021-2026) Table 52. Global Enoxaparin Sodium Sales by Region (2027-2032) & (M Units) Table 53. Global Enoxaparin Sodium Sales Market Share by Region (2027-2032) Table 54. Global Enoxaparin Sodium Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Enoxaparin Sodium Sales Value by Region (2021-2026) & (US$ Million) Table 56. Global Enoxaparin Sodium Sales Value Share by Region (2021-2026) Table 57. Global Enoxaparin Sodium Sales Value by Region (2027-2032) & (US$ Million) Table 58. Global Enoxaparin Sodium Sales Value Share by Region (2027-2032) Table 59. Global Enoxaparin Sodium Market Average Price (US$/Unit) by Region (2021-2026) Table 60. Global Enoxaparin Sodium Market Average Price (US$/Unit) by Region (2027-2032) Table 61. Global Enoxaparin Sodium Sales by Country: 2021 VS 2025 VS 2032 (M Units) Table 62. Global Enoxaparin Sodium Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Enoxaparin Sodium Sales by Country (2021-2026) & (M Units) Table 64. Global Enoxaparin Sodium Sales Market Share by Country (2021-2026) Table 65. Global Enoxaparin Sodium Sales by Country (2027-2032) & (M Units) Table 66. Global Enoxaparin Sodium Sales Market Share by Country (2027-2032) Table 67. Global Enoxaparin Sodium Sales Value by Country (2021-2026) & (US$ Million) Table 68. Global Enoxaparin Sodium Sales Value Market Share by Country (2021-2026) Table 69. Global Enoxaparin Sodium Sales Value by Country (2027-2032) & (US$ Million) Table 70. Global Enoxaparin Sodium Sales Value Market Share by Country (2027-2032) Table 71. Sanofi Company Information Table 72. Sanofi Business Overview Table 73. Sanofi Enoxaparin Sodium Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Sanofi Enoxaparin Sodium Product Portfolio Table 75. Sanofi Recent Development Table 76. Teva Company Information Table 77. Teva Business Overview Table 78. Teva Enoxaparin Sodium Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Teva Enoxaparin Sodium Product Portfolio Table 80. Teva Recent Development Table 81. Techdow (Hepalink) Company Information Table 82. Techdow (Hepalink) Business Overview Table 83. Techdow (Hepalink) Enoxaparin Sodium Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Techdow (Hepalink) Enoxaparin Sodium Product Portfolio Table 85. Techdow (Hepalink) Recent Development Table 86. Fresenius Kabi Company Information Table 87. Fresenius Kabi Business Overview Table 88. Fresenius Kabi Enoxaparin Sodium Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Fresenius Kabi Enoxaparin Sodium Product Portfolio Table 90. Fresenius Kabi Recent Development Table 91. Rovi Company Information Table 92. Rovi Business Overview Table 93. Rovi Enoxaparin Sodium Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Rovi Enoxaparin Sodium Product Portfolio Table 95. Rovi Recent Development Table 96. Amphastar Company Information Table 97. Amphastar Business Overview Table 98. Amphastar Enoxaparin Sodium Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Amphastar Enoxaparin Sodium Product Portfolio Table 100. Amphastar Recent Development Table 101. Nanjing King-friend Company Information Table 102. Nanjing King-friend Business Overview Table 103. Nanjing King-friend Enoxaparin Sodium Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Nanjing King-friend Enoxaparin Sodium Product Portfolio Table 105. Nanjing King-friend Recent Development Table 106. Sandoz Company Information Table 107. Sandoz Business Overview Table 108. Sandoz Enoxaparin Sodium Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Sandoz Enoxaparin Sodium Product Portfolio Table 110. Sandoz Recent Development Table 111. Apotex Company Information Table 112. Apotex Business Overview Table 113. Apotex Enoxaparin Sodium Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Apotex Enoxaparin Sodium Product Portfolio Table 115. Apotex Recent Development Table 116. Hangzhou Jiuyuan Gene Engineering Company Information Table 117. Hangzhou Jiuyuan Gene Engineering Business Overview Table 118. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Product Portfolio Table 120. Hangzhou Jiuyuan Gene Engineering Recent Development Table 121. Cipla Company Information Table 122. Cipla Business Overview Table 123. Cipla Enoxaparin Sodium Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Cipla Enoxaparin Sodium Product Portfolio Table 125. Cipla Recent Development Table 126. Taj Pharma Company Information Table 127. Taj Pharma Business Overview Table 128. Taj Pharma Enoxaparin Sodium Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Taj Pharma Enoxaparin Sodium Product Portfolio Table 130. Taj Pharma Recent Development Table 131. Chengdu Baiyu Pharmaceutical Company Information Table 132. Chengdu Baiyu Pharmaceutical Business Overview Table 133. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Product Portfolio Table 135. Chengdu Baiyu Pharmaceutical Recent Development Table 136. Suzhou Erye Pharmaceutical Company Information Table 137. Suzhou Erye Pharmaceutical Business Overview Table 138. Suzhou Erye Pharmaceutical Enoxaparin Sodium Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Suzhou Erye Pharmaceutical Enoxaparin Sodium Product Portfolio Table 140. Suzhou Erye Pharmaceutical Recent Development Table 141. Changzhou Qianhong Bio-pharma Company Information Table 142. Changzhou Qianhong Bio-pharma Business Overview Table 143. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Product Portfolio Table 145. Changzhou Qianhong Bio-pharma Recent Development Table 146. Hebei Changshan Biochemical Pharmaceutical Company Information Table 147. Hebei Changshan Biochemical Pharmaceutical Business Overview Table 148. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Product Portfolio Table 150. Hebei Changshan Biochemical Pharmaceutical Recent Development Table 151. Beijing SL Pharmaceutical Company Information Table 152. Beijing SL Pharmaceutical Business Overview Table 153. Beijing SL Pharmaceutical Enoxaparin Sodium Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Beijing SL Pharmaceutical Enoxaparin Sodium Product Portfolio Table 155. Beijing SL Pharmaceutical Recent Development Table 156. Huadong Medicine Company Information Table 157. Huadong Medicine Business Overview Table 158. Huadong Medicine Enoxaparin Sodium Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Huadong Medicine Enoxaparin Sodium Product Portfolio Table 160. Huadong Medicine Recent Development Table 161. Bharat Serums Company Information Table 162. Bharat Serums Business Overview Table 163. Bharat Serums Enoxaparin Sodium Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Bharat Serums Enoxaparin Sodium Product Portfolio Table 165. Bharat Serums Recent Development Table 166. INTAS Company Information Table 167. INTAS Business Overview Table 168. INTAS Enoxaparin Sodium Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 169. INTAS Enoxaparin Sodium Product Portfolio Table 170. INTAS Recent Development Table 171. LUPIN Company Information Table 172. LUPIN Business Overview Table 173. LUPIN Enoxaparin Sodium Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 174. LUPIN Enoxaparin Sodium Product Portfolio Table 175. LUPIN Recent Development Table 176. Troikaa Pharmaceuticals Company Information Table 177. Troikaa Pharmaceuticals Business Overview Table 178. Troikaa Pharmaceuticals Enoxaparin Sodium Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 179. Troikaa Pharmaceuticals Enoxaparin Sodium Product Portfolio Table 180. Troikaa Pharmaceuticals Recent Development Table 181. Aristopharma Company Information Table 182. Aristopharma Business Overview Table 183. Aristopharma Enoxaparin Sodium Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 184. Aristopharma Enoxaparin Sodium Product Portfolio Table 185. Aristopharma Recent Development Table 186. Fosun Pharma Company Information Table 187. Fosun Pharma Business Overview Table 188. Fosun Pharma Enoxaparin Sodium Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 189. Fosun Pharma Enoxaparin Sodium Product Portfolio Table 190. Fosun Pharma Recent Development Table 191. SciencePharma Company Information Table 192. SciencePharma Business Overview Table 193. SciencePharma Enoxaparin Sodium Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 194. SciencePharma Enoxaparin Sodium Product Portfolio Table 195. SciencePharma Recent Development Table 196. PISA Company Information Table 197. PISA Business Overview Table 198. PISA Enoxaparin Sodium Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 199. PISA Enoxaparin Sodium Product Portfolio Table 200. PISA Recent Development Table 201. Key Raw Materials Table 202. Raw Materials Key Suppliers Table 203. Enoxaparin Sodium Distributors List Table 204. Enoxaparin Sodium Customers List Table 205. Research Programs/Design for This Report Table 206. Authors List of This Report Table 207. Secondary Sources Table 208. Primary Sources List of Figures Figure 1. Enoxaparin Sodium Product Image Figure 2. Global Enoxaparin Sodium Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Enoxaparin Sodium Sales Value (2021-2032) & (US$ Million) Figure 4. Global Enoxaparin Sodium Sales (2021-2032) & (M Units) Figure 5. Global Enoxaparin Sodium Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Enoxaparin Sodium Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 20 mg/0.2mL Image Figure 10. 30 mg/0.3mL Image Figure 11. 40 mg/0.4mL Image Figure 12. 60 mg/0.6mL Image Figure 13. 80 mg/0.8mL Image Figure 14. 100 mg/1mL Image Figure 15. 120 mg/0.8mL Image Figure 16. 150 mg/1mL Image Figure 17. 300mg/3mL Image Figure 18. Global Enoxaparin Sodium Sales Volume by Type (2021 VS 2025 VS 2032) & (M Units) Figure 19. Global Enoxaparin Sodium Sales Volume Share 2021 VS 2025 VS 2032 Figure 20. Global Enoxaparin Sodium Sales Volume Share by Type (2021-2032) Figure 21. Global Enoxaparin Sodium Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Enoxaparin Sodium Sales Value Share 2021 VS 2025 VS 2032 Figure 23. Global Enoxaparin Sodium Sales Value Share by Type (2021-2032) Figure 24. Hospital Image Figure 25. Clinic Image Figure 26. Others Image Figure 27. Global Enoxaparin Sodium Sales Volume by Application (2021 VS 2025 VS 2032) & (M Units) Figure 28. Global Enoxaparin Sodium Sales Volume Share 2021 VS 2025 VS 2032 Figure 29. Global Enoxaparin Sodium Sales Volume Share by Application (2021-2032) Figure 30. Global Enoxaparin Sodium Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Enoxaparin Sodium Sales Value Share 2021 VS 2025 VS 2032 Figure 32. Global Enoxaparin Sodium Sales Value Share by Application (2021-2032) Figure 33. Global Enoxaparin Sodium Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 34. Global Enoxaparin Sodium Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 35. Global Enoxaparin Sodium Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 36. Global Enoxaparin Sodium Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 37. North America Enoxaparin Sodium Sales Value (2021-2032) & (US$ Million) Figure 38. North America Enoxaparin Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Europe Enoxaparin Sodium Sales Value (2021-2032) & (US$ Million) Figure 40. Europe Enoxaparin Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Asia-Pacific Enoxaparin Sodium Sales Value (2021-2032) & (US$ Million) Figure 42. Asia-Pacific Enoxaparin Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 43. South America Enoxaparin Sodium Sales Value (2021-2032) & (US$ Million) Figure 44. South America Enoxaparin Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 45. Middle East & Africa Enoxaparin Sodium Sales Value (2021-2032) & (US$ Million) Figure 46. Middle East & Africa Enoxaparin Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 47. USA Enoxaparin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. USA Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. USA Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Canada Enoxaparin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Canada Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Canada Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Mexico Enoxaparin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Mexico Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Mexico Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Germany Enoxaparin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Germany Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Germany Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. France Enoxaparin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. France Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. France Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. U.K. Enoxaparin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. U.K. Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. U.K. Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Italy Enoxaparin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Italy Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Italy Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Spain Enoxaparin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Spain Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Spain Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Russia Enoxaparin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Russia Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Russia Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Netherlands Enoxaparin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Netherlands Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Netherlands Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Nordic Countries Enoxaparin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Nordic Countries Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Nordic Countries Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. China Enoxaparin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. China Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. China Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Japan Enoxaparin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Japan Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Japan Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. South Korea Enoxaparin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. South Korea Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. South Korea Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. India Enoxaparin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. India Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. India Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Australia Enoxaparin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Australia Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Australia Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Southeast Asia Enoxaparin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Southeast Asia Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Southeast Asia Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Brazil Enoxaparin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Brazil Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Brazil Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Argentina Enoxaparin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Argentina Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Argentina Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Chile Enoxaparin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Chile Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Chile Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Colombia Enoxaparin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Colombia Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Colombia Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Peru Enoxaparin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Peru Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Peru Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Enoxaparin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Saudi Arabia Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Saudi Arabia Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Israel Enoxaparin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Israel Arabia Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Israel Arabia Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. UAE Enoxaparin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. UAE Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. UAE Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Turkey Enoxaparin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Turkey Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Turkey Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Iran Enoxaparin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Iran Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Iran Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Egypt Enoxaparin Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 129. Egypt Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 130. Egypt Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 131. Enoxaparin Sodium Value Chain Figure 132. Manufacturing Cost Structure Figure 133. Enoxaparin Sodium Sales Mode & Process Figure 134. Direct Comparison with Distribution Share Figure 135. Distributors Profiles Figure 136. Years Considered Figure 137. Research Process Figure 138. Key Executives Interviewed

Scope & coverage.

Types
  • 20 mg/0.2mL
  • 30 mg/0.3mL
  • 40 mg/0.4mL
  • 60 mg/0.6mL
  • 80 mg/0.8mL
  • 100 mg/1mL
  • 120 mg/0.8mL
  • 150 mg/1mL
  • 300mg/3mL
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Sanofi
  • Teva
  • Techdow (Hepalink)
  • Fresenius Kabi
  • Rovi
  • Amphastar
  • Nanjing King-friend
  • Sandoz
  • Apotex
  • Hangzhou Jiuyuan Gene Engineering
  • Cipla
  • Taj Pharma
  • Chengdu Baiyu Pharmaceutical
  • Suzhou Erye Pharmaceutical
  • Changzhou Qianhong Bio-pharma
  • Hebei Changshan Biochemical Pharmaceutical
  • Beijing SL Pharmaceutical
  • Huadong Medicine
  • Bharat Serums
  • INTAS
  • LUPIN
  • Troikaa Pharmaceuticals
  • Aristopharma
  • Fosun Pharma
  • SciencePharma
  • PISA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Enoxaparin Sodium Sales Value (2021-2032)
  4. 1.2.2 Global Enoxaparin Sodium Sales Volume (2021-2032)
  5. 1.2.3 Global Enoxaparin Sodium Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Enoxaparin Sodium Market Dynamics
  1. 2.1 Enoxaparin Sodium Industry Trends
  2. 2.2 Enoxaparin Sodium Industry Drivers
  3. 2.3 Enoxaparin Sodium Industry Opportunities and Challenges
  4. 2.4 Enoxaparin Sodium Industry Restraints
3 Enoxaparin Sodium Market by Company
  1. 3.1 Global Enoxaparin Sodium Company Revenue Ranking in 2025
  2. 3.2 Global Enoxaparin Sodium Revenue by Company (2021-2026)
  3. 3.3 Global Enoxaparin Sodium Sales Volume by Company (2021-2026)
  4. 3.4 Global Enoxaparin Sodium Average Price by Company (2021-2026)
  5. 3.5 Global Enoxaparin Sodium Company Ranking (2024-2026)
  6. 3.6 Global Enoxaparin Sodium Company Manufacturing Base and Headquarters
  7. 3.7 Global Enoxaparin Sodium Company Product Type and Application
  8. 3.8 Global Enoxaparin Sodium Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Enoxaparin Sodium Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Enoxaparin Sodium Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Enoxaparin Sodium Market by Type
  1. 4.1 Enoxaparin Sodium Type Introduction
  2. 4.1.1 20 mg/0.2mL
  3. 4.1.2 30 mg/0.3mL
  4. 4.1.3 40 mg/0.4mL
  5. 4.1.4 60 mg/0.6mL
  6. 4.1.5 80 mg/0.8mL
  7. 4.1.6 100 mg/1mL
  8. 4.1.7 120 mg/0.8mL
  9. 4.1.8 150 mg/1mL
  10. 4.1.9 300mg/3mL
  11. 4.2 Global Enoxaparin Sodium Sales Volume by Type
  12. 4.2.1 Global Enoxaparin Sodium Sales Volume by Type (2021 VS 2025 VS 2032)
  13. 4.2.2 Global Enoxaparin Sodium Sales Volume by Type (2021-2032)
  14. 4.2.3 Global Enoxaparin Sodium Sales Volume Share by Type (2021-2032)
  15. 4.3 Global Enoxaparin Sodium Sales Value by Type
  16. 4.3.1 Global Enoxaparin Sodium Sales Value by Type (2021 VS 2025 VS 2032)
  17. 4.3.2 Global Enoxaparin Sodium Sales Value by Type (2021-2032)
  18. 4.3.3 Global Enoxaparin Sodium Sales Value Share by Type (2021-2032)
5 Enoxaparin Sodium Market by Application
  1. 5.1 Enoxaparin Sodium Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Enoxaparin Sodium Sales Volume by Application
  6. 5.2.1 Global Enoxaparin Sodium Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Enoxaparin Sodium Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Enoxaparin Sodium Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Enoxaparin Sodium Sales Value by Application
  10. 5.3.1 Global Enoxaparin Sodium Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Enoxaparin Sodium Sales Value by Application (2021-2032)
  12. 5.3.3 Global Enoxaparin Sodium Sales Value Share by Application (2021-2032)
6 Enoxaparin Sodium Regional Sales and Value Analysis
  1. 6.1 Global Enoxaparin Sodium Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Enoxaparin Sodium Sales by Region (2021-2032)
  3. 6.2.1 Global Enoxaparin Sodium Sales by Region: 2021-2026
  4. 6.2.2 Global Enoxaparin Sodium Sales by Region (2027-2032)
  5. 6.3 Global Enoxaparin Sodium Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Enoxaparin Sodium Sales Value by Region (2021-2032)
  7. 6.4.1 Global Enoxaparin Sodium Sales Value by Region: 2021-2026
  8. 6.4.2 Global Enoxaparin Sodium Sales Value by Region (2027-2032)
  9. 6.5 Global Enoxaparin Sodium Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Enoxaparin Sodium Sales Value (2021-2032)
  12. 6.6.2 North America Enoxaparin Sodium Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Enoxaparin Sodium Sales Value (2021-2032)
  15. 6.7.2 Europe Enoxaparin Sodium Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Enoxaparin Sodium Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Enoxaparin Sodium Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Enoxaparin Sodium Sales Value (2021-2032)
  21. 6.9.2 South America Enoxaparin Sodium Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Enoxaparin Sodium Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Enoxaparin Sodium Sales Value Share by Country, 2025 VS 2032
7 Enoxaparin Sodium Country-level Sales and Value Analysis
  1. 7.1 Global Enoxaparin Sodium Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Enoxaparin Sodium Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Enoxaparin Sodium Sales by Country (2021-2032)
  4. 7.3.1 Global Enoxaparin Sodium Sales by Country (2021-2026)
  5. 7.3.2 Global Enoxaparin Sodium Sales by Country (2027-2032)
  6. 7.4 Global Enoxaparin Sodium Sales Value by Country (2021-2032)
  7. 7.4.1 Global Enoxaparin Sodium Sales Value by Country (2021-2026)
  8. 7.4.2 Global Enoxaparin Sodium Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Enoxaparin Sodium Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Enoxaparin Sodium Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Enoxaparin Sodium Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Enoxaparin Sodium Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Enoxaparin Sodium Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Enoxaparin Sodium Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Enoxaparin Sodium Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Enoxaparin Sodium Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Enoxaparin Sodium Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Enoxaparin Sodium Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Enoxaparin Sodium Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Enoxaparin Sodium Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Enoxaparin Sodium Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Enoxaparin Sodium Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Enoxaparin Sodium Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Enoxaparin Sodium Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Enoxaparin Sodium Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Enoxaparin Sodium Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Enoxaparin Sodium Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Enoxaparin Sodium Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Enoxaparin Sodium Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Enoxaparin Sodium Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Enoxaparin Sodium Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Enoxaparin Sodium Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Enoxaparin Sodium Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Enoxaparin Sodium Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Enoxaparin Sodium Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Enoxaparin Sodium Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Enoxaparin Sodium Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Enoxaparin Sodium Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Enoxaparin Sodium Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Enoxaparin Sodium Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Teva
  8. 8.2.1 Teva Company Information
  9. 8.2.2 Teva Business Overview
  10. 8.2.3 Teva Enoxaparin Sodium Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Teva Enoxaparin Sodium Product Portfolio
  12. 8.2.5 Teva Recent Developments
  13. 8.3 Techdow (Hepalink)
  14. 8.3.1 Techdow (Hepalink) Company Information
  15. 8.3.2 Techdow (Hepalink) Business Overview
  16. 8.3.3 Techdow (Hepalink) Enoxaparin Sodium Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Techdow (Hepalink) Enoxaparin Sodium Product Portfolio
  18. 8.3.5 Techdow (Hepalink) Recent Developments
  19. 8.4 Fresenius Kabi
  20. 8.4.1 Fresenius Kabi Company Information
  21. 8.4.2 Fresenius Kabi Business Overview
  22. 8.4.3 Fresenius Kabi Enoxaparin Sodium Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Fresenius Kabi Enoxaparin Sodium Product Portfolio
  24. 8.4.5 Fresenius Kabi Recent Developments
  25. 8.5 Rovi
  26. 8.5.1 Rovi Company Information
  27. 8.5.2 Rovi Business Overview
  28. 8.5.3 Rovi Enoxaparin Sodium Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Rovi Enoxaparin Sodium Product Portfolio
  30. 8.5.5 Rovi Recent Developments
  31. 8.6 Amphastar
  32. 8.6.1 Amphastar Company Information
  33. 8.6.2 Amphastar Business Overview
  34. 8.6.3 Amphastar Enoxaparin Sodium Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Amphastar Enoxaparin Sodium Product Portfolio
  36. 8.6.5 Amphastar Recent Developments
  37. 8.7 Nanjing King-friend
  38. 8.7.1 Nanjing King-friend Company Information
  39. 8.7.2 Nanjing King-friend Business Overview
  40. 8.7.3 Nanjing King-friend Enoxaparin Sodium Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Nanjing King-friend Enoxaparin Sodium Product Portfolio
  42. 8.7.5 Nanjing King-friend Recent Developments
  43. 8.8 Sandoz
  44. 8.8.1 Sandoz Company Information
  45. 8.8.2 Sandoz Business Overview
  46. 8.8.3 Sandoz Enoxaparin Sodium Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Sandoz Enoxaparin Sodium Product Portfolio
  48. 8.8.5 Sandoz Recent Developments
  49. 8.9 Apotex
  50. 8.9.1 Apotex Company Information
  51. 8.9.2 Apotex Business Overview
  52. 8.9.3 Apotex Enoxaparin Sodium Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Apotex Enoxaparin Sodium Product Portfolio
  54. 8.9.5 Apotex Recent Developments
  55. 8.10 Hangzhou Jiuyuan Gene Engineering
  56. 8.10.1 Hangzhou Jiuyuan Gene Engineering Company Information
  57. 8.10.2 Hangzhou Jiuyuan Gene Engineering Business Overview
  58. 8.10.3 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Product Portfolio
  60. 8.10.5 Hangzhou Jiuyuan Gene Engineering Recent Developments
  61. 8.11 Cipla
  62. 8.11.1 Cipla Company Information
  63. 8.11.2 Cipla Business Overview
  64. 8.11.3 Cipla Enoxaparin Sodium Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Cipla Enoxaparin Sodium Product Portfolio
  66. 8.11.5 Cipla Recent Developments
  67. 8.12 Taj Pharma
  68. 8.12.1 Taj Pharma Company Information
  69. 8.12.2 Taj Pharma Business Overview
  70. 8.12.3 Taj Pharma Enoxaparin Sodium Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Taj Pharma Enoxaparin Sodium Product Portfolio
  72. 8.12.5 Taj Pharma Recent Developments
  73. 8.13 Chengdu Baiyu Pharmaceutical
  74. 8.13.1 Chengdu Baiyu Pharmaceutical Company Information
  75. 8.13.2 Chengdu Baiyu Pharmaceutical Business Overview
  76. 8.13.3 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Product Portfolio
  78. 8.13.5 Chengdu Baiyu Pharmaceutical Recent Developments
  79. 8.14 Suzhou Erye Pharmaceutical
  80. 8.14.1 Suzhou Erye Pharmaceutical Company Information
  81. 8.14.2 Suzhou Erye Pharmaceutical Business Overview
  82. 8.14.3 Suzhou Erye Pharmaceutical Enoxaparin Sodium Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Suzhou Erye Pharmaceutical Enoxaparin Sodium Product Portfolio
  84. 8.14.5 Suzhou Erye Pharmaceutical Recent Developments
  85. 8.15 Changzhou Qianhong Bio-pharma
  86. 8.15.1 Changzhou Qianhong Bio-pharma Company Information
  87. 8.15.2 Changzhou Qianhong Bio-pharma Business Overview
  88. 8.15.3 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Product Portfolio
  90. 8.15.5 Changzhou Qianhong Bio-pharma Recent Developments
  91. 8.16 Hebei Changshan Biochemical Pharmaceutical
  92. 8.16.1 Hebei Changshan Biochemical Pharmaceutical Company Information
  93. 8.16.2 Hebei Changshan Biochemical Pharmaceutical Business Overview
  94. 8.16.3 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Product Portfolio
  96. 8.16.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments
  97. 8.17 Beijing SL Pharmaceutical
  98. 8.17.1 Beijing SL Pharmaceutical Company Information
  99. 8.17.2 Beijing SL Pharmaceutical Business Overview
  100. 8.17.3 Beijing SL Pharmaceutical Enoxaparin Sodium Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Beijing SL Pharmaceutical Enoxaparin Sodium Product Portfolio
  102. 8.17.5 Beijing SL Pharmaceutical Recent Developments
  103. 8.18 Huadong Medicine
  104. 8.18.1 Huadong Medicine Company Information
  105. 8.18.2 Huadong Medicine Business Overview
  106. 8.18.3 Huadong Medicine Enoxaparin Sodium Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Huadong Medicine Enoxaparin Sodium Product Portfolio
  108. 8.18.5 Huadong Medicine Recent Developments
  109. 8.19 Bharat Serums
  110. 8.19.1 Bharat Serums Company Information
  111. 8.19.2 Bharat Serums Business Overview
  112. 8.19.3 Bharat Serums Enoxaparin Sodium Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Bharat Serums Enoxaparin Sodium Product Portfolio
  114. 8.19.5 Bharat Serums Recent Developments
  115. 8.20 INTAS
  116. 8.20.1 INTAS Company Information
  117. 8.20.2 INTAS Business Overview
  118. 8.20.3 INTAS Enoxaparin Sodium Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 INTAS Enoxaparin Sodium Product Portfolio
  120. 8.20.5 INTAS Recent Developments
  121. 8.21 LUPIN
  122. 8.21.1 LUPIN Company Information
  123. 8.21.2 LUPIN Business Overview
  124. 8.21.3 LUPIN Enoxaparin Sodium Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 LUPIN Enoxaparin Sodium Product Portfolio
  126. 8.21.5 LUPIN Recent Developments
  127. 8.22 Troikaa Pharmaceuticals
  128. 8.22.1 Troikaa Pharmaceuticals Company Information
  129. 8.22.2 Troikaa Pharmaceuticals Business Overview
  130. 8.22.3 Troikaa Pharmaceuticals Enoxaparin Sodium Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Troikaa Pharmaceuticals Enoxaparin Sodium Product Portfolio
  132. 8.22.5 Troikaa Pharmaceuticals Recent Developments
  133. 8.23 Aristopharma
  134. 8.23.1 Aristopharma Company Information
  135. 8.23.2 Aristopharma Business Overview
  136. 8.23.3 Aristopharma Enoxaparin Sodium Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 Aristopharma Enoxaparin Sodium Product Portfolio
  138. 8.23.5 Aristopharma Recent Developments
  139. 8.24 Fosun Pharma
  140. 8.24.1 Fosun Pharma Company Information
  141. 8.24.2 Fosun Pharma Business Overview
  142. 8.24.3 Fosun Pharma Enoxaparin Sodium Sales, Value and Gross Margin (2021-2026)
  143. 8.24.4 Fosun Pharma Enoxaparin Sodium Product Portfolio
  144. 8.24.5 Fosun Pharma Recent Developments
  145. 8.25 SciencePharma
  146. 8.25.1 SciencePharma Company Information
  147. 8.25.2 SciencePharma Business Overview
  148. 8.25.3 SciencePharma Enoxaparin Sodium Sales, Value and Gross Margin (2021-2026)
  149. 8.25.4 SciencePharma Enoxaparin Sodium Product Portfolio
  150. 8.25.5 SciencePharma Recent Developments
  151. 8.26 PISA
  152. 8.26.1 PISA Company Information
  153. 8.26.2 PISA Business Overview
  154. 8.26.3 PISA Enoxaparin Sodium Sales, Value and Gross Margin (2021-2026)
  155. 8.26.4 PISA Enoxaparin Sodium Product Portfolio
  156. 8.26.5 PISA Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Enoxaparin Sodium Value Chain Analysis
  2. 9.1.1 Enoxaparin Sodium Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Enoxaparin Sodium Sales Mode & Process
  6. 9.2 Enoxaparin Sodium Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Enoxaparin Sodium Distributors
  9. 9.2.3 Enoxaparin Sodium Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst